Department Microbiology, National Reference Center for Burkholderia Cepacia Complex (NRC), Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
Department Microbiology, National Reference Center for Burkholderia Cepacia Complex (NRC), Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Antimicrob Agents Chemother. 2018 Aug 27;62(9). doi: 10.1128/AAC.00590-18. Print 2018 Sep.
We tested the susceptibility of ceftazidime-avibactam and ceftolozane-tazobactam and 13 other antibiotics against 91 complex (BCC) strains isolated from cystic fibrosis patients since 2012. The highest susceptibility (82%) was found for trimethoprim-sulfamethoxazole. Eighty-one and 63% of all BCC strains were susceptible to ceftazidime-avibactam and ceftolozane-tazobactam, respectively. For temocillin, ceftazidime, piperacillin-tazobactam, and meropenem, at least 50% of the strains were susceptible. seems to be more resistant than other BCC species.
我们测试了头孢他啶-阿维巴坦和头孢噻肟-他唑巴坦以及其他 13 种抗生素对 2012 年以来从囊性纤维化患者中分离出的 91 株复杂（BCC）菌株的敏感性。最高的敏感性（82%）被发现为复方磺胺甲噁唑。81%和 63%的所有 BCC 菌株对头孢他啶-阿维巴坦和头孢噻肟-他唑巴坦分别敏感。对于替莫西林、头孢他啶、哌拉西林-他唑巴坦和美罗培南，至少有 50%的菌株敏感。与其他 BCC 物种相比，似乎更具有耐药性。
